Skip to content
value.today

Advantagene, Inc.

Total raised
$77 M
6 rounds on record
Latest round
$29 M
Nov 2018
First round on record
Dec 2015
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Advantagene, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2018$29 MNo. 6$10 to $50 million

Advantagene, Inc.: Raise no. 6, Nov 2018

Investors in this round

18 investors had bought by the notice of Nov 26, 2018: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $29 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Estuardo Aguilar-Cordova · Executive Officer, Director
  • Laura Aguilar · Executive Officer
  • Stephen C. Rocamboli · Executive Officer
  • Alan C. Smith · Director
  • Chris C. Martell · Director
  • Edward J. Benz · Director
  • Paul C. Manning · Director
  • Sean C. Stalfort · Director
  • Udi C. Merav · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold in item 13 includes $3,703,470 from conversion of promissory notes.”

Signed by Stephen C. Rocamboli, Chief Business Officer. Source: SEC Form D, newest notice filed Nov 26, 2018. Read the notice at the SEC.

equity, optionsSEC
Aug 2016$14 MNo. 5$10 to $50 million

Advantagene, Inc.: Raise no. 5, Aug 2016

Investors in this round

251 investors had bought by the notice of Sep 14, 2016: 251 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $35 M offered; $21 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,583,787
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Estuardo Aguilar-Cordova · Executive Officer, Director
  • Laura Aguilar · Executive Officer
  • Stephen C. Rocamboli · Executive Officer
  • Alan C. Smith · Director
  • Fred C. Mermelstein · Director
  • Glenn C. Mattes · Director
  • Mitchell C. Finer · Director
  • Udi C. Merav · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New YorkSold in all US states

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”

Signed by Stephen C. Rocamboli, Chief Business Officer. Source: SEC Form D, newest notice filed Sep 14, 2016. Read the notice at the SEC.

equitySEC
Jun 2016$13 MNo. 4$10 to $50 million

Advantagene, Inc.: Raise no. 4, Jun 2016

Investors in this round

230 investors had bought by the notice of Jul 13, 2016: 230 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $35 M offered; $22 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,294,791
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Estuardo Aguilar-Cordova · Executive Officer, Director
  • Laura Aguilar · Executive Officer
  • Stephen C. Rocamboli · Executive Officer
  • Alan C. Smith · Director
  • Fred C. Mermelstein · Director
  • Glenn C. Mattes · Director
  • Mitchell C. Finer · Director
  • Udi C. Merav · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New YorkSold in all US states

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”

Signed by Stephen C. Rocamboli, Chief Business Officer. Source: SEC Form D, newest notice filed Jul 13, 2016. Read the notice at the SEC.

equitySEC
May 2016$10 MNo. 3$2 to $10 million

Advantagene, Inc.: Raise no. 3, May 2016

Investors in this round

191 investors had bought by the notice of Jun 13, 2016: 191 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $35 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,005,796
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Estuardo Aguilar-Cordova · Executive Officer, Director
  • Laura Aguilar · Executive Officer
  • Stephen C. Rocamboli · Executive Officer
  • Alan C. Smith · Director
  • Fred C. Mermelstein · Director
  • Glenn C. Mattes · Director
  • Mitchell C. Finer · Director
  • Udi C. Merav · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New YorkSold in all US states

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”

Signed by Stephen C. Rocamboli, Chief Business Officer. Source: SEC Form D, newest notice filed Jun 13, 2016. Read the notice at the SEC.

equitySEC
Apr 2016$9 MNo. 2$2 to $10 million

Advantagene, Inc.: Raise no. 2, Apr 2016

Investors in this round

166 investors had bought by the notice of May 16, 2016: 166 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $35 M offered; $26 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$877,709
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Estuardo Aguilar-Cordova · Executive Officer, Director
  • Laura Aguilar · Executive Officer
  • Stephen C. Rocamboli · Executive Officer
  • Alan C. Smith · Director
  • Fred C. Mermelstein · Director
  • Glenn C. Mattes · Director
  • Mitchell C. Finer · Director
  • Udi C. Merav · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · broker-dealer National Securities Corporation (CRD 7569) · New York, New YorkSold in all US states

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”

Signed by Stephen C. Rocamboli, Chief Business Officer. Source: SEC Form D and 1 amendment, newest notice filed May 16, 2016. Read the notice at the SEC.

equitySEC
Dec 2015$2 MNo. 1$2 to $10 million

Advantagene, Inc.: Raise no. 1, Dec 2015

Investors in this round

15 investors had bought by the notice of Dec 21, 2015: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Estuardo Aguilar-Cordova · Executive Officer, Director
  • Laura Aguilar · Executive Officer
  • Stephen C. Rocamboli · Executive Officer
  • Alan C. Smith · Director
  • Fred C. Mermelstein · Director
  • Glenn C. Mattes · Director
  • Mitchell C. Finer · Director
  • Udi C. Merav · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.”

Signed by Estuardo Aguilar-Cordova, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 21, 2015. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Advantagene, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2018).

    SEC Form D · Nov 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2018

That is all the official record says: Advantagene, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Advantagene, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 251 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Advantagene, Inc.
NameRoleNamed in
Estuardo Aguilar-CordovaExecutive officerNov 2018
Laura AguilarExecutive officerNov 2018
Stephen C. RocamboliExecutive officerNov 2018
Alan C. SmithDirectorNov 2018
Chris C. MartellDirectorNov 2018
Edward J. BenzDirectorNov 2018
Estuardo Aguilar-CordovaDirectorNov 2018
Paul C. ManningDirectorNov 2018
Sean C. StalfortDirectorNov 2018
Udi C. MeravDirectorNov 2018
Fred C. MermelsteinDirectorSep 2016
Glenn C. MattesDirectorSep 2016
Mitchell C. FinerDirectorSep 2016